Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class I · High risk Ongoing Initiated May 24, 2024 (2 years ago)

suntegrity (Zinc Oxide)

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

Microbial Contamination of Non-Sterile Products: Presence of Aspergillus Sydowii (Mold)

Cause type: Microbial contamination

Bacteria, mold, yeast or other microorganisms detected in the product. Contamination can occur from water systems, equipment or handling, and can cause infection. All microbial contamination recalls.

What was recalled

suntegrity, (Zinc Oxide 15%) IMPECCABLE SKIN sunscreen foundation, BUFF, Broad Spectrum SPF30, Net WT 2OZ (56.7 g), Suntegrity Skincare, Las Vegas, NV 89128, NDC: 69949-152-01 UPC 854245006187

Affected NDC 69949-0152-01

Compare with the code on your package — it is the most precise check available.

Drug: Zinc

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Impeccable Skin - Buff
Zinc Oxide
NDC 69949-0152
150 mg/g Cream
Topical
Synchronicity Spa, Inc. DBA Suntegrity OTC
Recalling firm
Synchronicity Spa INC, Dba Sunte
Origin
NV, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0588-2024 · FDA notice

Treat this as urgent. Class I means FDA judged there is a reasonable probability of serious harm. Find the lot number on your package; if it matches the recalled lots, do not take another dose before you have spoken to your pharmacist or prescriber - today, not next week.

Other Zinc recalls

See all
Class II · Moderate risk

Zicam

CGMP Deviations; FDA inspection of the contract manufacturer noted out of limit results for microbiological testing

Ongoing Microbial contamination Church & Dwight Co., Inc. D-0790-2026
Class II · Moderate risk

Med Pride

CGMP Deviations; deficiencies observed during FDA inspection

Ongoing cGMP deviation Dabur India Limited D-0642-2026
Class II · Moderate risk

Med Pride

CGMP Deviations; deficiencies observed during FDA inspection

Ongoing cGMP deviation Dabur India Limited D-0641-2026
Class II · Moderate risk

Med Pride

CGMP Deviations; deficiencies observed during FDA inspection

Ongoing cGMP deviation Dabur India Limited D-0637-2026

Other recalls by Synchronicity Spa INC, Dba Sunte

All 2024 recalls
Class II · Moderate risk

suntegrity

CGMP Deviations

Ongoing cGMP deviation Synchronicity Spa INC, Dba Sunte D-0589-2024